Multiomics Market Strengthened by AI and Big Data Integration

The global multiomics market is expected to experience significant growth over the next several years. Valued at an estimated US$ 2.8 billion in 2026, it is forecasted to reach US$ 4.6 billion by 2033, growing at a compound annual growth rate (CAGR) of 5.3% during the period from 2026 to 2033. This growth is driven by technological advancements in omics research, increasing applications across various industries, and the rising demand for personalized medicine. The market's expansion will also be fueled by the ongoing efforts in healthcare research, particularly in oncology, neurology, and immunology. In this article, we explore the scope, trends, competitive landscape, and market dynamics of the multiomics industry.